The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment

New Resources for Survival (PARTNERS) Program

Judith G. Regensteiner, William R. Hiatt, Joseph R. Coll, Michael H. Criqui, Diane Treat-Jacobson, Mary M. McDermott, Alan T. Hirsch, Thom W Rooke

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

This study tested the hypothesis that patients with PAD have impaired health-related quality of life (HRQoL) to a degree similar to that of patients with other types of cardiovascular disease (other-CVD), and also evaluated the clinical features of PAD associated with impaired HRQoL. This was a cross-sectional study in 350 primary care practice sites nationwide with 6,499 participants. The reference group had no clinical or hemodynamic evidence of PAD or other-CVD; the PAD group had an ankle-brachial index < 0.90 or a prior history of PAD; the other-CVD group had a clinical history of cardiac or cerebral vascular disease (but no PAD), and the combined PAD-other-CVD group included both diagnoses. Individuals were assessed using four HRQoL questionnaires including the Walking Impairment Questionnaire (WIQ), Medical Outcomes Study SF-36 (SF-36), Cantril Ladder of Life and the PAD Quality of Life questionnaire. PAD patients had lower WIQ distance scores than the other-CVD group. Both the PAD and other-CVD groups had significantly lower SF-36 Physical Function scores compared with the reference group. The WIQ revealed that PAD patients were more limited by calf pain, whereas other-CVD patients were more limited by chest pain, shortness of breath and palpitations. In conclusion, in this nationwide study, one of the first to directly compare the HRQoL burden of CVD with that of PAD, the evaluation of PAD in office practice revealed a HRQoL burden as great in magnitude as in patients with other forms of CVD.

Original languageEnglish (US)
Pages (from-to)15-24
Number of pages10
JournalVascular Medicine
Volume13
Issue number1
DOIs
StatePublished - 2008

Fingerprint

Peripheral Arterial Disease
Cardiovascular Diseases
Quality of Life
Survival
Walking
Therapeutics
Ankle Brachial Index
Chest Pain
Vascular Diseases
Dyspnea
Primary Health Care
Cross-Sectional Studies
Hemodynamics
Outcome Assessment (Health Care)
Surveys and Questionnaires
Pain

Keywords

  • Cardiovascular disease
  • Claudication
  • Functional status
  • Health-related quality of life
  • Peripheral arterial disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment : New Resources for Survival (PARTNERS) Program. / Regensteiner, Judith G.; Hiatt, William R.; Coll, Joseph R.; Criqui, Michael H.; Treat-Jacobson, Diane; McDermott, Mary M.; Hirsch, Alan T.; Rooke, Thom W.

In: Vascular Medicine, Vol. 13, No. 1, 2008, p. 15-24.

Research output: Contribution to journalArticle

Regensteiner, Judith G. ; Hiatt, William R. ; Coll, Joseph R. ; Criqui, Michael H. ; Treat-Jacobson, Diane ; McDermott, Mary M. ; Hirsch, Alan T. ; Rooke, Thom W. / The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment : New Resources for Survival (PARTNERS) Program. In: Vascular Medicine. 2008 ; Vol. 13, No. 1. pp. 15-24.
@article{2234eb6ed75c422aa5e11344dc847b6e,
title = "The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program",
abstract = "This study tested the hypothesis that patients with PAD have impaired health-related quality of life (HRQoL) to a degree similar to that of patients with other types of cardiovascular disease (other-CVD), and also evaluated the clinical features of PAD associated with impaired HRQoL. This was a cross-sectional study in 350 primary care practice sites nationwide with 6,499 participants. The reference group had no clinical or hemodynamic evidence of PAD or other-CVD; the PAD group had an ankle-brachial index < 0.90 or a prior history of PAD; the other-CVD group had a clinical history of cardiac or cerebral vascular disease (but no PAD), and the combined PAD-other-CVD group included both diagnoses. Individuals were assessed using four HRQoL questionnaires including the Walking Impairment Questionnaire (WIQ), Medical Outcomes Study SF-36 (SF-36), Cantril Ladder of Life and the PAD Quality of Life questionnaire. PAD patients had lower WIQ distance scores than the other-CVD group. Both the PAD and other-CVD groups had significantly lower SF-36 Physical Function scores compared with the reference group. The WIQ revealed that PAD patients were more limited by calf pain, whereas other-CVD patients were more limited by chest pain, shortness of breath and palpitations. In conclusion, in this nationwide study, one of the first to directly compare the HRQoL burden of CVD with that of PAD, the evaluation of PAD in office practice revealed a HRQoL burden as great in magnitude as in patients with other forms of CVD.",
keywords = "Cardiovascular disease, Claudication, Functional status, Health-related quality of life, Peripheral arterial disease",
author = "Regensteiner, {Judith G.} and Hiatt, {William R.} and Coll, {Joseph R.} and Criqui, {Michael H.} and Diane Treat-Jacobson and McDermott, {Mary M.} and Hirsch, {Alan T.} and Rooke, {Thom W}",
year = "2008",
doi = "10.1177/1358863X07084911",
language = "English (US)",
volume = "13",
pages = "15--24",
journal = "Vascular Medicine (United Kingdom)",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment

T2 - New Resources for Survival (PARTNERS) Program

AU - Regensteiner, Judith G.

AU - Hiatt, William R.

AU - Coll, Joseph R.

AU - Criqui, Michael H.

AU - Treat-Jacobson, Diane

AU - McDermott, Mary M.

AU - Hirsch, Alan T.

AU - Rooke, Thom W

PY - 2008

Y1 - 2008

N2 - This study tested the hypothesis that patients with PAD have impaired health-related quality of life (HRQoL) to a degree similar to that of patients with other types of cardiovascular disease (other-CVD), and also evaluated the clinical features of PAD associated with impaired HRQoL. This was a cross-sectional study in 350 primary care practice sites nationwide with 6,499 participants. The reference group had no clinical or hemodynamic evidence of PAD or other-CVD; the PAD group had an ankle-brachial index < 0.90 or a prior history of PAD; the other-CVD group had a clinical history of cardiac or cerebral vascular disease (but no PAD), and the combined PAD-other-CVD group included both diagnoses. Individuals were assessed using four HRQoL questionnaires including the Walking Impairment Questionnaire (WIQ), Medical Outcomes Study SF-36 (SF-36), Cantril Ladder of Life and the PAD Quality of Life questionnaire. PAD patients had lower WIQ distance scores than the other-CVD group. Both the PAD and other-CVD groups had significantly lower SF-36 Physical Function scores compared with the reference group. The WIQ revealed that PAD patients were more limited by calf pain, whereas other-CVD patients were more limited by chest pain, shortness of breath and palpitations. In conclusion, in this nationwide study, one of the first to directly compare the HRQoL burden of CVD with that of PAD, the evaluation of PAD in office practice revealed a HRQoL burden as great in magnitude as in patients with other forms of CVD.

AB - This study tested the hypothesis that patients with PAD have impaired health-related quality of life (HRQoL) to a degree similar to that of patients with other types of cardiovascular disease (other-CVD), and also evaluated the clinical features of PAD associated with impaired HRQoL. This was a cross-sectional study in 350 primary care practice sites nationwide with 6,499 participants. The reference group had no clinical or hemodynamic evidence of PAD or other-CVD; the PAD group had an ankle-brachial index < 0.90 or a prior history of PAD; the other-CVD group had a clinical history of cardiac or cerebral vascular disease (but no PAD), and the combined PAD-other-CVD group included both diagnoses. Individuals were assessed using four HRQoL questionnaires including the Walking Impairment Questionnaire (WIQ), Medical Outcomes Study SF-36 (SF-36), Cantril Ladder of Life and the PAD Quality of Life questionnaire. PAD patients had lower WIQ distance scores than the other-CVD group. Both the PAD and other-CVD groups had significantly lower SF-36 Physical Function scores compared with the reference group. The WIQ revealed that PAD patients were more limited by calf pain, whereas other-CVD patients were more limited by chest pain, shortness of breath and palpitations. In conclusion, in this nationwide study, one of the first to directly compare the HRQoL burden of CVD with that of PAD, the evaluation of PAD in office practice revealed a HRQoL burden as great in magnitude as in patients with other forms of CVD.

KW - Cardiovascular disease

KW - Claudication

KW - Functional status

KW - Health-related quality of life

KW - Peripheral arterial disease

UR - http://www.scopus.com/inward/record.url?scp=42649098207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42649098207&partnerID=8YFLogxK

U2 - 10.1177/1358863X07084911

DO - 10.1177/1358863X07084911

M3 - Article

VL - 13

SP - 15

EP - 24

JO - Vascular Medicine (United Kingdom)

JF - Vascular Medicine (United Kingdom)

SN - 1358-863X

IS - 1

ER -